Sessions
Overcoming Scale Up Process Development Challenges for Pluripotent Stem Cell Derived Therapies
Technology, Disruptive Innovation and Partnerships that are Revolutionizing How Medicines Are Made
Future-Proofing Cell Therapy Production
Add It Up: 3 Things to Consider for Capacity Expansion
Unlocking the Potential of Advanced Therapies Through Collaborations
Why So Shy? Implementing Disruptive Technologies with Confidence in Cell Therapy
Overcoming Scale Up Process Development Challenges for Pluripotent Stem Cell Derived Therapies
27 Jan 2022
17:00
Briefing Room
SPONSORED BY
Moderator:
Breanna Borys, Bioprocess Scientist, PBS Biotech
Panellists:
Yina Santiago-Rodriguez, Process Development Manager, Fujifilm Cellular Dynamics
Benjamin Fryer, Co-Founder and CEO, Pluristyx Inc
Speakers
